SpringWorks Therapeutics price target lowered to $78 from $80 at Guggenheim
Guggenheim analyst Michael Schmidt lowered the firm’s price target on SpringWorks Therapeutics (SWTX) to $78 from $80 and ...
Salesforce Stock’s AI Rally Is Over, Analyst Says. Why Now Could Be the Time to Sell.
Salesforce ended 2024 on a high note but fell on Monday after a Guggenheim analyst downgraded shares of the software company.
Time Out16d
All the art exhibits coming to NYC's Guggenheim Museum in 2025
With its stunning Frank Lloyd Wright design, the Guggenheim Museum is a piece of art in itself. Inside these rounded walls, you’ll find floor upon floor of artistic treasures. The modern and ...
Guggenheim Doubts Salesforce's Agentic AI Agentforce as an Effective Growth Factor
Agentforce was launched in September and already signed up 200 companies to deploy Agentforce as their smarter chatbot. Marc ...
Palo Alto Networks downgraded to Sell from Neutral at Guggenheim
Guggenheim downgraded Palo Alto Networks (PANW) to Sell from Neutral with a $130 price target Stay Ahead of the Market:Discover outperforming ...
Why Palo Alto Networks Stock Dropped on Wednesday
Each successive downgrade has cost Palo Alto stock a few more points of market capitalization. Today, the stock fell 4% to ...
Bloomberg L.P.1mon
Guggenheim’s Walsh Sees Private Credit Doubling in Size
Chief investment officer of Guggenheim Partners Investment Management Anne Walsh sees the private credit market potentially doubling in size to $4 trillion globally. Speaking on a panel at ...
Rubrik price target raised to $76 from $72 at Guggenheim
Guggenheim analyst John DiFucci raised the firm’s price target on Rubrik (RBRK) to $76 from $72 and keeps a Buy rating on the shares. The firm ...
Orphism, the early 20th century art movement, in focus at New York’s Guggenheim Museum
The exhibition spotlights a contradictory modern art movement that, though it celebrated technological advances, was rooted ...
BroadwayWorld1d
Guggenheim Museum
Guggenheim New York is an icon of adventurous originality. Experience special exhibitions in our iconic, spiraling rotunda, plus highlights from our collection by Picasso, Degas, and Van Gogh.
Guggenheim sees potential in Primoris, starts with a Buy
As previously reported, Guggenheim analyst Joseph Osha initiated coverage of Primoris (PRIM) with a Buy rating and $102 price target The firm ...